It is time to share Alzheimer biomarker results in dementia with Lewy bodies
There are increasing calls for biomarker result sharing in dementia research.No processes exist to guide result sharing in dementia with Lewy bodies (DLB).Alzheimer biomarker results in DLB are valid, interpretable, and actionable.Research is needed on the methods and effects of sharing with people with DLB.Research is needed for sharing evidence of co-pathology across neurodegenerations.
Authors
- Thomas Francis Tropea (ORCID: https://orcid.org/0000-0003-0766-1496)
- Melissa J. Armstrong (ORCID: https://orcid.org/0000-0002-2163-1907)
- Joshua D. Grill (ORCID: https://orcid.org/0000-0002-4215-7589)
Institutions
- University of California, Irvine (US)
- University of Florida (US)
- Institute for Neurodegenerative Disorders (US)
- University of Pennsylvania (US)
- Florida College (US)
Publication Details
- Journal
- Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1002/dad2.70144
- Citations
- 4
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 5.88
Funders
- National Institutes of Health